REQUEST A DEMO
Total
USD $0.00
Search more companies

Alteogen Inc. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Scientific Research and Development Services
Full name: Alteogen Inc. Profile Updated: July 06, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Alteogen Inc. is a bio company located in Daejeon, South Korea. Founded in 2008, the company specializes in next-generation biologics. Their portfolio includes biobetters with improved efficacy compared to existing biologics, biosimilars that demonstrate comparability to existing biologics, and proprietary biologics. Alteogen focuses on three cutting-edge areas of the industry: long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars with complexity. They have developed NexP Fusion Technology, a next-generation long-acting biobetter technology, NexMab ADC Technology, an Antibody-Drug Conjugate technology, and a novel human hyaluronidase PH 20 based on Hybrozyme Technology. Additionally, Alteogen is involved in joint development of Antibody Biosimilars with overseas strategic alliance partners.

Headquarters
305, Daejeon Bio Venture Town, 62, Yuseong-Daero 1628Beon-G, Yuseong-Gu, Daejeon
Daejeon; Daejeon;

Contact Details: Purchase the Alteogen Inc. report to view the information.

Website: http://www.alteogen.com

Basic Information
Total Employees:
Purchase the Alteogen Inc. report to view the information.
Outstanding Shares:
Purchase the Alteogen Inc. report to view the information.
Registered Capital:
Purchase the Alteogen Inc. report to view the information.
Financial Auditors:
Purchase the Alteogen Inc. report to view the information.
Incorporation Date:
May 13, 2008
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
22.4%
Purchase this report to view the information.
4.6%
Purchase this report to view the information.
0.7%
Subsidiaries
(주)바이오사이언스
100%
(주)엘에스메디텍
100%
(주)세레스에프엔디
77%
Company Performance
Financial values in the chart are available after Alteogen Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-10.85%
Total operating revenue
-18.84%
Operating profit (EBIT)
-10.63%
EBITDA
-32.55%
Net Profit (Loss) for the Period
-0.17%
Total assets
13.14%
Total equity
11.16%
Operating Profit Margin (ROS)
0.06%
Net Profit Margin
4.02%
Return on Equity (ROE)
-1.08%
Debt to Equity Ratio
-43.59%
Quick Ratio
0.13%
Cash Ratio
0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?